COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,674 Articles (22,913 medRxiv, 8,761 bioRxiv)

Most recent first Previous |  Page 393: Articles 3921-3930  | Next

Meisoindigo: An Effective Inhibitor of SARS-CoV-2 Main Protease Revealed by Yeast System
Grabinski, W., Kicinska, A., Kosicka, E., Baranek-Grabinska, M., Hejenkowska, E. D., Budzik, J., Sliska, P., Sliwinska, W., Karachitos, A.
10.1101/2023.09.03.555867 — Posted: 2023-09-04
Sensitivity of BA.2.86 to prevailing neutralising antibody responses
Sheward, D. J., Yang, Y., Westerberg, M., Öling, S., Muschiol, S., Sato, K., Peacock, T. P., Karlsson Hedestam, G. B., Albert, J., Murrell, B.
10.1101/2023.09.02.556033 — Posted: 2023-09-04
Multi-omics profiling reveals phenotypic and functional heterogeneity of neutrophils in COVID-19
Zhang, L., Nishi, H., Kinoshita, K.
10.1101/2023.09.02.556069 — Posted: 2023-09-04
Trapping non-cognate nucleotide upon initial binding for replication fidelity control in SARS-CoV-2 RNA dependent RNA polymerase
Romero, M. E., McElhenney, S. J., Yu, J.
10.1101/2023.09.01.555996 — Posted: 2023-09-04
Reference materials for SARS-CoV-2 molecular diagnostic: validation of encapsulated synthetic RNAs for room temperature storage and shipping
Colotte, M., Luis, A., Bonnet, J., Coudy, D., Tuffet, S., Robene, I., Fenelon, B., Jouen, E., Leveque, N., Alain, S., Plumelle, D., Tumiotto, C., Busson, L., Lafon, M.-E.
10.1101/2023.08.28.555008 — Posted: 2023-09-04
Ensitrelvir Fumaric Acid in Patients with SARS-CoV-2: A Retrospective Chart Review
Yamato, M., Kinoshita, M., Miyazawa, S., Seki, M., Mizuno, T., Sonoyama, T.
10.1101/2023.09.03.23294865 — Posted: 2023-09-03
Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial
Hendrick, J., Ma, J. Z., Haughey, H. M., Coleman, R., Nayak, U., Kadl, A., Sturek, J. M., Jackson, P., Young, M. K., Allen, J. E., Petri, W. A.
10.1101/2023.09.01.23293947 — Posted: 2023-09-02
A mathematical model for multiple COVID-19 waves applied to Kenya
Ogana, W., Juma, V. O., Bulimo, W. D., Chiteri, V. N.
10.1101/2023.09.01.23294943 — Posted: 2023-09-02
COVID-19-related school closures, United States, July 27, 2020 - June 30, 2022
Zviedrite, N., Jahan, F. A., Moreland, S., Ahmed, F., Uzicanin, A.
10.1101/2023.08.31.23294738 — Posted: 2023-09-02
Application of MALDI-MS and Machine Learning to Detection of SARS-CoV-2 and non-SARS-CoV-2 Respiratory Infections.
Yegorov, S., Kadyrova, I., Korshukov, I., Sultanbekova, A., Barkhanskaya, V., Bashirova, T., Zhunusov, Y., Li, Y., Parakhina, V., Kolesnichenko, S., Baiken, Y., Matkarimov, B., Vazenmiller, D., Miller, M. S., Hortelano, G. H., Turmuhambetova, A., Chesca, A. E., Babenko, D.
10.1101/2023.08.31.23294891 — Posted: 2023-09-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).